PL1919483T3 - Preparat złożony z diuretyku pętlowego i diuretyku tiazydowego - Google Patents

Preparat złożony z diuretyku pętlowego i diuretyku tiazydowego

Info

Publication number
PL1919483T3
PL1919483T3 PL06791717T PL06791717T PL1919483T3 PL 1919483 T3 PL1919483 T3 PL 1919483T3 PL 06791717 T PL06791717 T PL 06791717T PL 06791717 T PL06791717 T PL 06791717T PL 1919483 T3 PL1919483 T3 PL 1919483T3
Authority
PL
Poland
Prior art keywords
diuretic
loop
combined preparation
thiazide
combination
Prior art date
Application number
PL06791717T
Other languages
English (en)
Inventor
Heinrich Knauf
Ernst Mutschler
Original Assignee
Heinrich Knauf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heinrich Knauf filed Critical Heinrich Knauf
Publication of PL1919483T3 publication Critical patent/PL1919483T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
PL06791717T 2005-08-29 2006-08-29 Preparat złożony z diuretyku pętlowego i diuretyku tiazydowego PL1919483T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005040841A DE102005040841A1 (de) 2005-08-29 2005-08-29 Kombinationspräparat aus einem Thiaziddiuretikum und einem Schleifendiuretikum
PCT/EP2006/008455 WO2007025721A1 (de) 2005-08-29 2006-08-29 Kombinationspräparat aus einem thiaziddiuretikum und einem schleifendiuretikum
EP06791717A EP1919483B1 (de) 2005-08-29 2006-08-29 Kombinationspräparat aus einem thiaziddiuretikum und einem schleifendiuretikum

Publications (1)

Publication Number Publication Date
PL1919483T3 true PL1919483T3 (pl) 2010-06-30

Family

ID=37517115

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06791717T PL1919483T3 (pl) 2005-08-29 2006-08-29 Preparat złożony z diuretyku pętlowego i diuretyku tiazydowego

Country Status (12)

Country Link
US (1) US20090023714A1 (pl)
EP (1) EP1919483B1 (pl)
JP (1) JP2009506088A (pl)
CN (1) CN101252938A (pl)
AT (1) ATE453396T1 (pl)
AU (1) AU2006286755A1 (pl)
CA (1) CA2620647A1 (pl)
DE (2) DE102005040841A1 (pl)
DK (1) DK1919483T3 (pl)
ES (1) ES2339156T3 (pl)
PL (1) PL1919483T3 (pl)
WO (1) WO2007025721A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102557995A (zh) * 2011-12-14 2012-07-11 天津药物研究院药业有限责任公司 N-乙氧甲酰基-5-氯-2-甲基-4-氨磺酰基苯胺的合成方法
JP5932738B2 (ja) * 2013-09-02 2016-06-08 キヤノン株式会社 電子機器及び電子機器の制御部への電力制御方法

Also Published As

Publication number Publication date
DE502006005798D1 (de) 2010-02-11
ATE453396T1 (de) 2010-01-15
JP2009506088A (ja) 2009-02-12
DK1919483T3 (da) 2010-05-10
CA2620647A1 (en) 2007-03-08
ES2339156T3 (es) 2010-05-17
AU2006286755A1 (en) 2007-03-08
CN101252938A (zh) 2008-08-27
WO2007025721A1 (de) 2007-03-08
EP1919483B1 (de) 2009-12-30
EP1919483A1 (de) 2008-05-14
US20090023714A1 (en) 2009-01-22
DE102005040841A1 (de) 2007-03-01

Similar Documents

Publication Publication Date Title
EP2260833A3 (en) Bilayer pharmaceutical tablet comprising telmisartan and a diuretic
SG155188A1 (en) Pyrrole derivatives as pharmaceutical agents
EP1778405A4 (en) FEEDING MECHANISM WITH LOADING SEMINAR SETTING FOR USE IN THE AUTOMATIC HIGH-SECURE DESTRUCTION OF MIXED LOADS AND OTHER FEEDING SYSTEMS
JO3492B1 (ar) تركيبات صيدلانية من مضاد مستقبل أنجيوتنسين ومثبط nep
NO20063997L (no) Tablett med flere lag
NO20051033L (no) Preparat omfattende en kolesterolabsorpsjonsinhibitor, en HMF-CoA-reduktaseinhibitor og et stabiliserende middel
WO2005070462A3 (en) Compositions comprising (s)-amlodipine and an angiotensin receptor blocker and methods of their use
WO2007001067A3 (en) Solid dosage form comprising an angiotensin ii receptor antagonist and a calcium channel blocker
WO2006137934A3 (en) Purposeful movement of human migratory cells away from an agent source
MXPA04000586A (es) Combinacion de un atagonista del receptor de aldosterona con un inhibidor de la hmg coa reductasa.
IL184048A0 (en) Triazolone, tetrazolone and imidazolone derivatives for use as alpha-2c adrenoreceptor antagonists
WO2005011652A3 (en) Use of a vitamin d receptor activator or a vitamin d analog to treat kidney disease
TW200637546A (en) Combination therapy
WO2005007137A3 (de) Ambroxolhaltige tabletten
MXPA05006399A (es) Metodos y formas de dosificacion para reducir los ataques al corazon en un individuo hipertenso con un diuretico o una combinacion de un diuretico y un inhibidor de la eca.
TW200628174A (en) Bilayer tablet
AU2003295870A8 (en) Membrane for fuel cell, and fuel cell incorporating that membrane
WO2006020680A3 (en) Heterocyclic compounds as pharmaceutical agents
PL1919483T3 (pl) Preparat złożony z diuretyku pętlowego i diuretyku tiazydowego
DE60320800D1 (de) Verwendung von saatmehl als bodenpestizid
Wuerzner et al. Renin inhibition with aliskiren.
TW200501953A (en) Combination therapy for hypertension using lercanidipine and an angiotensin II receptor blocker
CL2008002555A1 (es) Composicion farmaceutica que comprende un compuesto de levosimendan y un segundo ingrediente activo un antagonista del receptor de angiotensiva ii; un kit farmaceutico que comprende dicha composicion; y su uso para la prevencion o la inhibicion de apoplejia.
MY146956A (en) Combination of an inhibitor of the if current of the sinus node and an inhibitor of the angiotensin converting enzyme
AU2002229611A1 (en) Use of active compounds capable of modulating the intracellular pathway triggered by the dp receptor in langerhans cells